PL2934568T3
Dual glp1/gip or trigonal glp1/gip/glucagon agonists
Abstract
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.

Term
7.2 yearsto projected expiry
Projected expiry 19 December 2033, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
8 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8
118 members in 37 offices
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 12306647 | European Patent Office (EPO) | A | |
| 12306647 | European Patent Office (EPO) | A | |
| 13811510 | European Patent Office (EPO) | A | |
| 2013077313 | European Patent Office (EPO) | W | |
| 2013077313 | European Patent Office (EPO) | W | |
| 12306647 | – | – | – |
| 138115100 | – | – | – |
| EP20120306647 | – | – | – |
| EP20130811510 | – | – | – |
| WO2013EP77313 | – | – | – |
Members118
| Document | Office | Kind | |
|---|---|---|---|
| CA2894765A1 | Canada | A1 | |
| CA2895156A1 | Canada | A1 | |
| CA2895755A1 | Canada | A1 | |
| CA2895875A1 | Canada | A1 | |
| WO2014096145A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2014096148A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2014096149A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2014096150A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2014206608A1 | United States of America | A1 | |
| US2014206609A1 | United States of America | A1 | |
| US2014213513A1 | United States of America | A1 | |
| UY35231A | Uruguay | A | |
| UY35232A | Uruguay | A | |
| UY35233A | Uruguay | A | |
| UY35234A | Uruguay | A | |
| TW201429985A | Taiwan Province of China | A | |
| US2014221281A1 | United States of America | A1 | |
| TW201441251A | Taiwan Province of China | A | |
| TW201441252A | Taiwan Province of China | A | |
| TW201443080A | Taiwan Province of China | A | |
| SG11201503524PA | Singapore | A | |
| SG11201503526UA | Singapore | A | |
| SG11201503576XA | Singapore | A | |
| SG11201504215PA | Singapore | A | |
| AU2013360721A1 | Australia | A1 | |
| AU2013366690A1 | Australia | A1 | |
| AU2013366691A1 | Australia | A1 | |
| AU2013366692A1 | Australia | A1 | |
| AR094178A1 | Argentina | A1 | |
| AR094180A1 | Argentina | A1 | |
| AR094181A1 | Argentina | A1 | |
| KR20150096398A | Republic of Korea | A | |
| KR20150096433A | Republic of Korea | A | |
| PH12015501291A1 | Philippines | A1 | |
| PH12015501291B1 | Philippines | B1 | |
| KR20150096684A | Republic of Korea | A | |
| CN104870009A | China | A | |
| DOP2015000156A | Dominican Republic | A | |
| KR20150099548A | Republic of Korea | A | |
| PE20151239A1 | Peru | A1 | |
| CN104902918A | China | A | |
| CN104902919A | China | A | |
| CN104902920A | China | A | |
| CR20150358A | Costa Rica | A | |
| CL2015001751A1 | Chile | A1 | |
| EP2934566A1 | European Patent Office (EPO) | A1 | |
| EP2934567A1 | European Patent Office (EPO) | A1 | |
| EP2934568A1 | European Patent Office (EPO) | A1 | |
| EP2934569A1 | European Patent Office (EPO) | A1 | |
| MX2015008077A | Mexico | A | |
| MX2015008079A | Mexico | A | |
| MX2015008114A | Mexico | A | |
| ECSP15031141A | Ecuador | A | |
| JP2016503770A | Japan | A | |
| JP2016503771A | Japan | A | |
| JP2016503772A | Japan | A | |
| JP2016506401A | Japan | A | |
| EA201591174A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MX2015008099A | Mexico | A | |
| HK1211231A1 | Hong Kong, China | A1 | |
| HK1211232A1 | Hong Kong, China | A1 | |
| HK1211233A1 | Hong Kong, China | A1 | |
| HK1213483A1 | Hong Kong, China | A1 | |
| AR099912A1 | Argentina | A1 | |
| TN2015000283A1 | Tunisia | A1 | |
| ZA201503914B | South Africa | B | |
| RU2015129696A | Russian Federation | A | |
| RU2015129815A | Russian Federation | A | |
| RU2015129788A | Russian Federation | A | |
| US9670261B2 | United States of America | B2 | |
| EP2934566B1 | European Patent Office (EPO) | B1 | |
| MA38276A1 | Morocco | A1 | |
| SG10201705097PA | Singapore | A | |
| US2017216406A1 | United States of America | A1 | |
| US9745360B2 | United States of America | B2 | |
| TWI600663B | Taiwan Province of China | B | |
| BR112015014800A2 | Brazil | A2 | |
| EP2934568B1 | European Patent Office (EPO) | B1 | |
| TWI602828B | Taiwan Province of China | B | |
| BR112015013809A2 | Brazil | A2 | |
| AR105816A2 | Argentina | A2 | |
| BR112015014510A2 | Brazil | A2 | |
| AU2013366692B2 | Australia | B2 | |
| PT2934568T | Portugal | T | |
| CL2016002182A1 | Chile | A1 | |
| DK2934568T3 | Denmark | T3 | |
| AU2013366690B2 | Australia | B2 | |
| ES2653765T3 | Spain | T3 | |
| LT2934568T | Lithuania | T | |
| HRP20180092T1 | Croatia | T1 | |
| MA38276B1 | Morocco | B1 | |
| PL2934568T3This record | Poland | T3 | |
| SI2934568T1 | Slovenia | T1 | |
| UA116553C2 | Ukraine | C2 | |
| RU2652783C2 | Russian Federation | C2 | |
| EP2934567B1 | European Patent Office (EPO) | B1 | |
| HUE035803T2 | Hungary | T2 | |
| DK2934567T3 | Denmark | T3 | |
| EP2934567B9 | European Patent Office (EPO) | B9 | |
| LT2934567T | Lithuania | T |
Showing 100 of 118
Numbers
- Publication
- 2934568
- Publication, DOCDB
- 2934568
- Publication, EPODOC
- PL2934568T
- Application
- 13811510
- Application, DOCDB
- 13811510
- Application, EPODOC
- PL20130811510T
Titles2
- English
- DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS
- Polish
- Agonista podwójny GLP1/GIP lub potrójny GLP1/GIP/glukagon
Classification
- CPC, 23
- C07K14/605
- A61K38/26
- A61K38/00
- A61K38/2264
- A61K45/06
- A61K38/28
- A61P1/00
- A61P1/16
- A61P25/00
- A61P25/28
- A61P25/30
- A61P3/00
- A61P3/04
- A61P3/06
- A61P3/08
- A61P39/02
- A61P43/00
- A61P9/00
- A61P9/10
- A61P9/12
- A61P3/10
- Y02A50/30
- A61K9/0019
- IPC, 6
- A61K38 00
- A61K38 22
- A61K38 26
- A61K38 28
- A61K45 06
- C07K14 605